From: In vitro and in vivo evaluation of pharmacological potential of Begonia barbata Wall
Treatment | % Reduction of blood glucose level | ||
---|---|---|---|
Hour after administration of plant sample/drug | |||
1 h | 2 h | 3 h | |
Glibenclamide (2 mg/kg) | 33.93 | 24.28 | 39.79 |
PEF (200 mg/kg) | 37.49 | 23.49 | 2.65 |
PEF (400 mg/kg) | 26.45 | 35.51 | 16.98 |
DCMF (200 mg/kg) | 39.50 | 20.89 | 38.99 |
DCMF (400 mg/kg) | 35.11 | 29.50 | 28.38 |
EAF (200 mg/kg) | 17.32 | 32.90 | 10.61 |
EAF (400 mg/kg) | 29.18 | 7.57 | 7.96 |